JoVE Logo

Oturum Aç

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be technically challenging.

The elimination rate constant can be determined through the rate constant method and the sigma minus method. Both involve plotting the natural logarithm of the plasma concentration versus time or the difference between plasma concentrations at two time points versus time, with the line slope equating to the elimination rate constant. To ensure validity, urinary excretion data should exhibit a linear relationship between urinary excretion and time, a steady excretion rate, and sufficient data points.

In conclusion, urinary excretion data and determining the elimination rate constant are integral to pharmacokinetic analysis, offering valuable insights into drug elimination and clearance within the body.

Etiketler

One Compartment Open ModelUrinary Excretion DataRenal ClearanceDrug EliminationKidney FunctionElimination Rate ConstantSigma Minus MethodPharmacokinetic AnalysisPlasma Drug ConcentrationLinear RelationshipSteady Excretion RateDrug Clearance

Bölümden 7:

article

Now Playing

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

Pharmacokinetic Models

102 Görüntüleme Sayısı

article

7.1 : Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Pharmacokinetic Models

66 Görüntüleme Sayısı

article

7.2 : Model Approaches for Pharmacokinetic Data: Compartment Models

Pharmacokinetic Models

61 Görüntüleme Sayısı

article

7.3 : One-Compartment Open Model for IV Bolus Administration: General Considerations

Pharmacokinetic Models

125 Görüntüleme Sayısı

article

7.4 : One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

Pharmacokinetic Models

142 Görüntüleme Sayısı

article

7.5 : One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Pharmacokinetic Models

48 Görüntüleme Sayısı

article

7.6 : One-Compartment Model: IV Infusion

Pharmacokinetic Models

129 Görüntüleme Sayısı

article

7.7 : One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Pharmacokinetic Models

45 Görüntüleme Sayısı

article

7.8 : One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

Pharmacokinetic Models

175 Görüntüleme Sayısı

article

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

Pharmacokinetic Models

257 Görüntüleme Sayısı

article

7.11 : Multicompartment Models: Overview

Pharmacokinetic Models

70 Görüntüleme Sayısı

article

7.12 : Two-Compartment Open Model: Overview

Pharmacokinetic Models

82 Görüntüleme Sayısı

article

7.13 : Two-Compartment Open Model: IV Bolus Administration

Pharmacokinetic Models

284 Görüntüleme Sayısı

article

7.14 : Two-Compartment Open Model: IV Infusion

Pharmacokinetic Models

178 Görüntüleme Sayısı

article

7.15 : Two-Compartment Open Model: Extravascular Administration

Pharmacokinetic Models

121 Görüntüleme Sayısı

See More

JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır